Aura Biosciences AURA
NASDAQ AURA
$7.48 +0.11 (+1.49%)
As of: Sep 4, 2026 · 2:32 PM EDT

Aura Biosciences (AURA) Interest Coverage Ratio (2022)

Aura Biosciences' (AURA) quarterly Interest Coverage Ratio came in at 1.48 in Q1 2026, up 86.74% YoY from 0.79 in Q1 2025, and up 95.42% on a QoQ basis from 32.39 in Q4 2025.

Analysis

Aura Biosciences (AURA) Interest Coverage Ratio (2022) Analysis & Trends

Aura Biosciences (AURA) has 7 years of Interest Coverage Ratio data on file, last reported at 1.48 in Q1 2026.

  • Quarterly Interest Coverage Ratio rose 86.74% year-over-year to 1.48 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.05 (up 87.26% YoY) and the FY2025 annual result came in at 34.12, down 186.38% from the prior year.
  • Interest Coverage Ratio grew to 1.48 in Q1 2026, from 32.39 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.21 in Q1 2022 to a low of 34.04 in Q4 2024.
  • A 5-year average of 8.78 and a median of 1.79 in 2023 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 99.69% — and 2023, when it tumbled 636.27%.
  • Tracing AURA's Interest Coverage Ratio over 5 years: stood at 22.93 in 2022, then plunged by 36.27% to 31.25 in 2023, then dropped by 8.91% to 34.04 in 2024, then climbed by 4.85% to 32.39 in 2025, then jumped by 95.42% to 1.48 in 2026.
  • The last three Interest Coverage Ratio figures came in at 1.48 (Q1 2026), 32.39 (Q4 2025), and 3.75 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 117.59
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -493.00
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -21.24
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.41 Bn 27.57 Bn - 1.42
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -0.08
10 Aura Biosciences 711.48 Mn 643.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -2,763.20